Skip to Main Content

Paper Details

Development of CDK2 and CDK5 Dual Degrader TMX-2172.
Angew Chem Int Ed Engl
40
2020
ATP, CCNE1, CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK9, Cyclin-dependent kinase 2, OVCAR8, TMX-2172, cancer, cancers, cell cycle CDKs, cyclin E1, ovarian cancer, transcriptional CDKs
Author NameAffiliation
Caitlin E MillsHarvard Medical School
Peter K SorgerHarvard Medical School
Nathanael S GrayDana-Farber Cancer Institute, Harvard Medical School
Nathanael S GrayHarvard Medical School
Nathanael S GrayDana-Farber Cancer Institute, Harvard Medical School
Nathanael S GrayHarvard Medical School
  • 1 - 6

Datasets

Release 1.2